Education
About Us
Working with TipRanks
Follow Us
SGS SA (CH:SGSN)
:SGSN
Top Page
SGS SA
(SGSN)
Select Model
Select Model
Rating:67Neutral
Price Target:
CHF102.00
▲(8.01% Upside)
Action:ReiteratedDate:02/18/26
The score is driven by strong earnings/cash-flow momentum and a positive 2026 outlook from the latest call, supported by a constructive (but not overextended) technical trend. These positives are tempered most by elevated balance-sheet leverage and a valuation that looks relatively rich at ~27x earnings despite a ~3.4% dividend yield.
Positive Factors
Strong free cash flow
SGS's consistently high free cash flow and strong cash conversion provide durable internal funding for capex, dividends, M&A and deleveraging. Reliable FCF improves resilience through cycles, enabling disciplined capital allocation and cushioning against cyclical revenue swings.
Diversified organic growth
Multiple business lines and regions delivering sustained organic growth reduce reliance on any single market. This diversification supports revenue stability, spreads regulatory and cyclical risk, and underpins reliable demand for testing, inspection and certification services long term.
High ROIC and efficiency gains
Industry-leading ROIC and realized procurement/efficiency savings demonstrate structural margin and capital efficiency. Sustained efficiency programs boost competitive advantage, free up cash for strategic investment, and improve return profile even if top-line growth moderates.
Negative Factors
Elevated leverage
Substantially elevated leverage and thin equity limit balance-sheet flexibility and increase refinancing and covenant risk. High gross debt constrains strategic optionality, raises interest burden sensitivity, and makes the company more vulnerable to macro shocks over the medium term.
Significant FX headwind
Material and persistent currency translation effects reduce reported growth and compress margins, eroding visibility and complicating planning. As a global services provider, sustained FX volatility can materially alter reported results and cash flow comparability over multiple quarters.
Cyclical segment exposure
Exposure to cyclical end markets like natural resources and agriculture introduces durable revenue volatility tied to commodity cycles and weather/political risk. This variability can pressure margins, require periodic restructuring, and complicate forecasting and resource allocation across years.
SGS SA (SGSN) vs. iShares MSCI Switzerland ETF (EWL)
Market Cap
CHF18.09B
Dividend Yield3.53%
Average Volume (3M)343.65K
Price to Earnings (P/E)26.1
Beta (1Y)0.79
Revenue Growth3.12%
EPS Growth11.70%
CountryCH
Employees95,244
SectorIndustrials
Sector Strength72
IndustryConsulting Services
Share Statistics
EPS (TTM)2.00
Shares Outstanding194,777,280
10 Day Avg. Volume319,408
30 Day Avg. Volume343,653
Financial Highlights & Ratios
PEG Ratio2.07
Price to Book (P/B)19.36
Price to Sales (P/S)2.51
P/FCF Ratio18.02
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
CHF95.17Price Target Upside0.77% Upside
Rating ConsensusHold
Number of Analyst Covering6
EPS Forecast (FY)4.13
Revenue Forecast (FY)CHF7.50B
SGS SA Business Overview & Revenue Model
Company DescriptionSGS SA provides inspection, verification, testing, certification, and quality assurance services in Europe, Africa, the Middle East, the Americas, and the Asia Pacific. It operates in five segments: Connectivity & Products, Health & Nutrition, Industries & Environment, Natural Resources and Knowledge. The company provides laboratory testing, product inspection and consulting, process assessment, technical and transactional assistance; digital solutions, which include cybersecurity, the internet of things, digital platform, and mobile application services. In addition, it offers a range of testing, inspection and certification solutions for the crop science, food, health science, and cosmetics and hygiene industries; field services, technical assessment and advisory services; and services related to industrial, public health and safety, environmental testing, and public mandates. Further, it provides certification, training, supply chain assurance, technical consulting, and ESG assurance services; and laboratory outsourcing, commodities logistics, geochemistry, metallurgy, sustainability, and market intelligence solutions. The company serves the agriculture and food, chemical, construction, consumer and retail, energy, industrial manufacturing, life sciences, mining, oil and gas, public, and transportation sectors. SGS SA was founded in 1878 and is headquartered in Geneva, Switzerland.
How the Company Makes MoneySGS generates revenue primarily through its diverse range of services, which include testing, inspection, and certification. The company operates through multiple business lines: Testing, Inspection, Certification, and Verification. Key revenue streams include fees for product testing and analysis, quality assurance services, and regulatory compliance assessments. Additionally, SGS has established significant partnerships with various industries to provide tailored services, which further solidifies its market presence. Factors contributing to its earnings include the growing emphasis on safety and quality standards across industries, the expansion of regulatory frameworks worldwide, and the increasing demand for sustainable practices among businesses.
SGS SA Earnings Call Summary
Earnings Call Date:Feb 11, 2026
(Q4-2025)
| % Change Since: |
Next Earnings Date:Jul 29, 2026
Earnings Call Sentiment Positive
The call presents a predominantly positive performance: record sales, record adjusted operating income and free cash flow, strong organic growth across multiple divisions and regions, successful execution of efficiency programs and a clear strategic M&A push (notably ATS and ~CHF 190m of bolt-on sales). Key risks highlighted were a significant foreign-exchange headwind, regional/sector variability (notably in Natural Resources and consulting), ongoing restructuring and nonrecurring items, and a temporary post-acquisition leverage uptick. Management emphasizes disciplined M&A, continued reinvestment into digital and sustainability capabilities, and a conservative approach to margins (maintaining a 16% AOI floor while reserving flexibility to invest surplus). Overall, positive operational momentum is balanced against macro (FX, geopolitical) and timing uncertainties, but the highlights materially outweigh the lowlights.Q4-2025 Updates
Positive Updates
Record Sales
Sales reached a record CHF 6.95 billion in FY2025, driven by 5.6% organic growth and 1.7% from M&A; reported growth was 2.2% (adversely impacted by ForEx).
Record Adjusted Operating Income and Margin Expansion
Adjusted operating income hit a record CHF 1.1 billion, representing a 16.0% AOI margin — an improvement of 70 basis points vs 2024 and 130 basis points vs 2023 (Strategy 27 baseline).
Record Free Cash Flow and Strong Cash Conversion
Free cash flow was a record CHF 774 million (57% cash conversion on adjusted EBITDA). With CHF 67 million net proceeds from HQ disposal, total free cash flow reached CHF 841 million.
Earnings Per Share Growth
Earnings per share increased to CHF 3.48 (+12.3%). Excluding the HQ disposal gain, EPS was CHF 3.21, up 3.5% year-on-year.
Operational Efficiency and Procurement Savings
Lean operating model and procurement plans delivered CHF 115 million visible savings to the P&L since 2024, achieving a CHF 150 million run rate at end-2025; an additional CHF 35 million is expected to flow through in 2026.
Strong ROIC and Attractive Leverage
Return on invested capital (ROIC) remained industry-leading at 24%; net debt to adjusted EBITDA improved to 1.7x (pre-ATS closing).
Strategic M&A and North America Expansion (ATS)
Acquisition of Applied Technical Services (ATS) closed in January 2026 to bolster North America presence; bolt-on M&A program added seven companies since last update, representing approximately CHF 190 million of annualised sales.
Broad-Based Organic Growth by Division and Region
Multiple business lines delivered strong organic growth: Health & Nutrition +7.3% (AOI margin 14.1%), Industries & Environment +6.5% (margin 13.1%), Connectivity & Products +6.4% (margin 22.8%), Business Assurance +4.2% (margin 19.6%), Natural Resources +3.4% (margin 13.6%). Regional organic growth: Asia Pacific +7.7%, Latin America +13.6%, North America +3.9%, EMEA +5.3%, Europe +2.4%.
Sustainability and Digital Trust Momentum
Sustainability-related services grew ~15% (strong organic performance) and Digital Trust delivered double-digit growth (both organic and from acquisitions), underpinning strategic priorities and future double-digit potential.
Stakeholder and ESG Progress
Customer satisfaction increased to 92%; 7.7 million training hours provided; maintained leading ESG ratings and inclusion for a second year in Times World's Most Sustainable Companies list.
Shareholder Returns Maintained
Board intends to propose an attractive dividend of CHF 3.20 per share (scrip dividend option retained; >60% take-up historically), balancing returns with growth and M&A funding.
Negative Updates
Significant ForEx Headwind
Adverse foreign exchange reduced reported sales growth by 5.1% and subtracted the equivalent of 6.4% from adjusted operating income (c.20 basis points on AOI margin); management flagged a potential c.8% FX impact in Q1 2026 if current rates persist.
Reported Growth vs Organic
Reported sales growth was only +2.2% due to strong Swiss franc appreciation despite healthy organic growth of +5.6%.
Natural Resources Softness and Agricultural Headwind
Natural Resources organic growth was only +3.4%; agriculture was negatively impacted by a weak crop in Europe and political uncertainty/reduced trading volumes in some EMEA markets.
Consulting Weakness in Business Assurance
Consulting remained soft within Business Assurance (despite sustainability and Digital Trust strength), limiting the division's overall growth to +4.2% organic.
Nonrecurring and Restructuring Costs
Restructuring expenses decreased from peak but remained ~CHF 45 million in 2025 with guidance of CHF 20–40 million for 2026; other nonrecurring items can fluctuate and historical averages near CHF 120 million were noted.
Temporary Leverage Increase Post-ATS
Following the ATS close, net debt/EBITDA is expected to temporarily rise to around 2.1–2.2x before gradual reduction in subsequent years.
Margin Upside Partly Reinvested
Management intends to preserve flexibility to invest surplus into innovation and digital/AI capabilities, meaning not all margin gains will flow to the bottom line — 16% AOI margin is a minimum target for 2026 rather than an ambition to push significantly higher.
Division and Regional Variability
Some segments and regions experienced uneven performance (e.g., Natural Resources, parts of Connectivity & Products in Europe) and high comparables (e.g., ISO certification post-certification cycle) constrained short-term comparability.
Pharma Drug Development Softness
Pharma growth was mixed: clinical research in Europe performed well while drug development (U.S.) remained softer, tempering overall Health & Nutrition/Pharma momentum.
Uncertainty Around Timing of Certain Benefits
Some savings and M&A synergies are phased (additional CHF 35 million procurement savings to flow in 2026; ATS synergies and CHF 30 million planned savings referenced for future years), so near-term benefit timing has some uncertainty.
Company Guidance
For 2026 management guided organic growth of 5–7%, expects more than +5% additional sales from acquisitions (including ATS, closed Jan‑2026), and will maintain a minimum 16% adjusted operating income margin in reported terms while retaining flexibility to reinvest surplus into innovation; this follows record 2025 metrics: sales CHF 6.95bn, adjusted operating income CHF 1.1bn (16%, +70bps vs 2024), free cash flow CHF 774m (57% cash conversion) or CHF 841m including CHF 67m HQ disposal proceeds, EPS CHF 3.48 (+12.3%) or CHF 3.21 (+3.5%) excluding the HQ gain, reported sales growth +2.2% (7.3% constant currency = 5.6% organic +1.7% M&A). Operational efficiencies reached CHF 115m P&L impact since 2024 with a CHF 150m run‑rate at end‑2025 and ~CHF 35m still to flow through in 2026; net debt/EBITDA was 1.7x (temporarily ~2.1–2.2x post‑ATS), ROIC 24%, proposed scrip dividend CHF 3.20/share, and management warned FX remains a headwind (‑5.1% sales impact in 2025, ~‑20bps on AOI and an ~‑8% FX effect seen in Q1‑2026 at current rates).SGS SA Financial Statement Overview
Summary
Operations and cash flow are solid (income statement score 78; cash flow score 72 with consistently strong operating cash flow and high free cash flow), but the balance sheet is a major constraint (balance sheet score 38) due to very high leverage and thin equity, which elevates financial risk.Income Statement
Revenue has been resilient overall, with a sharp acceleration in 2025 (34.3% growth vs ~2.6% in 2024), supporting higher profits (net income up to 668M from 581M). Profitability appears solid for the business model, but margins show some pressure versus earlier years (EBITDA margin was ~23.1% in 2021 vs ~20.5% in 2024), and 2020–2023 growth was uneven (including slight contraction in 2023).78
Positive
Balance Sheet
Leverage is the key weakness: debt is high relative to equity across the period (debt-to-equity ~4.9x in 2024 and ~9.6x in 2023), and total debt rose materially in 2025 (to 5.3B from 3.88B in 2024). Equity remains relatively thin (901M in 2025 vs 7.88B assets), which limits balance-sheet flexibility even though the company has grown assets over time.38
Negative
Cash Flow
Cash generation is a clear strength: operating cash flow has been consistently strong and stable (~1.0–1.2B annually), and free cash flow remains high (968M in 2025; 973M in 2024). Free cash flow has generally tracked profit well (free cash flow to net income ~0.66–0.79 in 2021–2024), though growth has been choppy (negative in 2021–2022, improving in 2023–2025).72
Positive
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 6.95B | 6.79B | 6.62B | 6.64B | 6.41B |
| Gross Profit | 5.97B | 5.83B | 2.36B | 2.41B | 2.34B |
| EBITDA | 1.50B | 1.40B | 1.36B | 1.40B | 1.48B |
| Net Income | 668.00M | 581.00M | 553.00M | 588.00M | 613.00M |
Balance Sheet | |||||
| Total Assets | 7.88B | 6.75B | 6.76B | 7.12B | 7.01B |
| Cash, Cash Equivalents and Short-Term Investments | 2.33B | 1.21B | 1.57B | 1.62B | 1.48B |
| Total Debt | 5.30B | 3.88B | 4.41B | 4.45B | 3.81B |
| Total Liabilities | 6.89B | 5.87B | 6.23B | 6.36B | 5.80B |
| Stockholders Equity | 901.00M | 797.00M | 459.00M | 682.00M | 1.12B |
Cash Flow | |||||
| Free Cash Flow | 968.00M | 973.00M | 825.00M | 653.00M | 782.00M |
| Operating Cash Flow | 1.22B | 1.22B | 1.12B | 985.00M | 1.12B |
| Investing Cash Flow | -310.00M | -393.00M | -300.00M | -397.00M | -549.00M |
| Financing Cash Flow | 289.00M | -1.19B | -839.00M | -375.00M | -826.00M |
SGS SA Technical Analysis
Positive
94.44
Price Trends
93.83
Positive
91.68
Positive
87.51
Positive
Market Momentum
0.42
Positive
50.91
Neutral
48.11
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CH:SGSN, the sentiment is Positive. The current price of 94.44 is below the 20-day moving average (MA) of 94.72, above the 50-day MA of 93.83, and above the 200-day MA of 87.51, indicating a neutral trend. The MACD of 0.42 indicates Positive momentum. The RSI at 50.91 is Neutral, neither overbought nor oversold. The STOCH value of 48.11 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for CH:SGSN.
SGS SA Peers Comparison
UnderperformOutperform
Sector (63)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
67 Neutral | CHF18.09B | 26.12 | ― | 3.53% | 3.12% | 11.70% | |
67 Neutral | CHF3.88B | 18.40 | ― | 4.14% | 2.66% | 2.91% | |
66 Neutral | CHF6.37B | 58.76 | 5.71% | 2.13% | 4.23% | -4.24% | |
64 Neutral | CHF5.76B | 25.28 | 22.69% | 1.82% | 8.15% | 12.24% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | CHF21.01B | 22.29 | ― | 4.81% | 6.54% | -10.57% | |
60 Neutral | CHF3.53B | 14.14 | ― | 4.46% | -4.68% | -5.79% |
* Industrials Sector Average
CH:SGSN
SGS SA
93.18
7.79
9.12%
CH:AVOL
Avolta AG
46.80
7.35
18.65%
CH:KNIN
Kuehne + Nagel International AG
176.95
-23.72
-11.82%
CH:ADEN
Adecco Group AG
21.06
-5.55
-20.86%
CH:DKSH
DKSH Holding AG
59.80
-8.78
-12.80%
CH:VZN
VZ Holding AG
146.60
-6.25
-4.09%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.